MHB018A Treatment in Patients With Chronic Thyroid Eye Disease

NCT07257185 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Eye Disease (TED)

Interventions

DRUG: MHB018A injection
DRUG: MHB018A injection Placebo

Sponsor

Minghui Pharmaceutical (Hangzhou) Ltd